A Majority of Low (1-10%) ER Positive Breast Cancers Behave Like Hormone Receptor Negative Tumors

Por Prabhu, Jyothi S., Korlimarla, Aruna, Desai, Krisha, Alexander, Annie, Raghavan, Rohini, Anupama, CE, Dendukuri, Nandini, Manjunath, Suraj, Correa, Marjorrie, Raman, N, Kalamdani, Anjali, Prasad, MSN, Gopinath, K.S, Srinath, B.S., Sridhar, T.S.
Publicado em 2014

Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease

Por Prabhu, Jyothi S, Korlimarla, Aruna, Anupama, C E, Alexander, Annie, Raghavan, Rohini, Kaul, Roma, Desai, Krisha, Rajarajan, Savitha, Manjunath, Suraj, Correa, Marjorrie, Raman, R, Kalamdani, Anjali, Prasad, MSN, Patil, Shekar, Gopinath, K S, Srinath, B S, Sridhar, T.S.
Publicado no Transl Oncol (2017)